Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Guidant (GDT) -- Ignore unavailable to you. Want to Upgrade?

To: Stuolson who wrote (69)	12/19/1997 9:48:00 AM
From: JMS	Respond to of 235

The drop cannot go too far from here because the earnings/growth will support the stock price, even in crappy market conditions. GDT seems to get ahead of itself once in a while-multiples of 70 or so at the top. Fact is, earnings on Feb 3 will be around .45-.50. Slap a historical multiple on that, multiply it by .8 for a shit market and decide if you should buy in the mid 50's. AVEI has been up on anticipation of stent approval-they are a one-trick pony, so be careful.

To: Stuolson who wrote (69)	12/20/1997 12:03:00 PM
From: Loren	Read Replies (1) \| Respond to of 235

Suolson - Don't really know... my TA tools simply show me that there is a developed downtrend in place, and that's why I had to sell out of my position (capital preservation!). JMS may be right, it may not go much further before it becomes a VALUE play to the market. However, I don't buy on value... I buy on GROWTH and a developed UPTREND. Maybe the next one will happen soon! I am now intrigued by this company since they make ICD's, and I happen to have one in me! Loren